Letter

Reduction in mortality from breast cancer

BMJ 2005; 330 doi: 10.1136/bmj.330.7498.1025-a (Published 28 April 2005)
Cite this as: BMJ 2005;330:1025.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Reasons for improved survival are more complex than suggested

  1. Graeme W Morgan, director (gmorgan1@bigpond.net.au)
  1. Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW 2065, Australia

    EDITOR—Although no supporting data are given, Jones in her editorial proposes that adjuvant treatments with chemotherapy or hormones are more likely than screening to be responsible for reduction in breast cancer mortality.1 However, the reason(s) for the improved survival is much more …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular